Beta to Alpha

Share this post
Will Covid-19 separate the wheat from the chaff in the Indian pharma industry? (Part 2 of 2)
betatoalpha.substack.com

Will Covid-19 separate the wheat from the chaff in the Indian pharma industry? (Part 2 of 2)

Let's delve deeper.

Saket Mehrotra
Sep 17, 2020
Share this post
Will Covid-19 separate the wheat from the chaff in the Indian pharma industry? (Part 2 of 2)
betatoalpha.substack.com

If we compare the Operating Profit margins of most of the pharmaceutical companies in India (domestic as well as MNC players) they are more or less in the 19-23% bracket. But when it comes to ROCE, the MNC pack is clearly the outperformer. Let’s have a look here.

Keep reading with a 7-day free trial

Subscribe to Beta to Alpha to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2022 Saket Mehrotra
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing